Sergio A. Quezada
Oncology · 2004–2023
A researcher in the Science corpus: 16 papers; trusts 3 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 209 citations into it; #1,307 of 1,698 by trust here, #145 by citations
- Immunology — 199 citations into it; #1,293 of 2,160 by trust here, #227 by citations
Whom Sergio A. Quezada trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Sergio A. Quezada overall
Papers from Sergio A. Quezada's perspective
Ordered by how strongly the researchers Sergio A. Quezada trusts endorse each paper. Same corpus, a different order for every researcher.
- Modulation of tryptophan catabolism by regulatory T cells (Nature Immunology)
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
- CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. (Journal of Clinical Investigation)
- Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. (Journal of Clinical Investigation)
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes (Science)
- Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4 (Journal of Experimental Medicine)
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens (Journal of Clinical Oncology)
- Foxp3 instability leads to the generation of pathogenic memory T cells in vivo (Nature Immunology)
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
- Tumor-specific Th17-polarized cells eradicate large established melanoma. (Blood)
Their papers
- Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution (2017) — 1,156 citations
- Lung adenocarcinoma promotion by air pollutants (2023) — 655 citations
- Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition (2021) — 716 citations
- Neoantigen directed immune escape in lung cancer evolution (2019) — 783 citations
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic (2018) — 2,243 citations
- Tracking the Evolution of Non‐Small‐Cell Lung Cancer (2017) — 2,016 citations
- Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis. (2017) — 782 citations
- Phylogenetic ctDNA analysis depicts early stage lung cancer evolution (2017) — 1,635 citations
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade (2016) — 2,796 citations
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity (2015) — 1,014 citations
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma (2013) — 1,396 citations
- Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts (2010) — 881 citations
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies (2009) — 936 citations
- CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. (2006) — 685 citations
- Cutting Edge: Contact-Mediated Suppression by CD4+CD25+ Regulatory Cells Involves a Granzyme B-Dependent, Perforin-Independent Mechanism1 (2005) — 991 citations
- CD40/CD154 interactions at the interface of tolerance and immunity. (2004) — 757 citations